28.01.2021: PHASE I VACCINE STUDIES IN THE TIMES OF COVID-19

Phase 1 Vaccine Studies in the Times of Covid-19

Free webinar on 28 January 2021 at 16:00-17:45 CET

Invitation to our Early Medicines Development Community

COVID has highlighted the importance of Phase 1 trials with vaccines. And yet, only a handful of sponsors, Phase 1 sites and investigators have a thorough understanding of the science, methodology, ethics and logistics required to run such trials.

Our New Years EUFEMED webinar will provide you with cutting-edge insight into newest developments around such trials while also learning about the experience of others and providing an opportunity to discuss recommendations.

Registration & FAQ

What to expect

from 15:40	dial-in
Moderator:	Jan de Hoon Center for Clinical Pharmacology, KU Leuven, Belgium
16:00	Welcome and Introduction
16:10	An overview of current vaccine platforms and the development of a new vaccine against SARS-CoV-2 Johan Neyts, Rega Institute, KU Leuven, Belgium Q&A
16:40	The challenges of setting up a Phase 1 vaccine trial during the Corona pandemic: The sponsor’s point of view Johan Van Hoof, Janssen Pharmaceutica, Beerse, Belgium Q&A
17:10	The challenges of conducting a Phase 1 vaccine trial during the Corona pandemic: The investigator’s point of view Wouter Botermans, Center for Clinical Pharmacology, KU Leuven, Belgium Q&A
17:30	General Discussion
17:40	Closing remarks

Registration	Free of charge (requested at the latest by 25/1/2021)
Organizer	*EUFEMED* www.eufemed.eu
Contact	via CSi Hamburg GmbH Email: eufemed2021@csihamburg.de Phone: +49 40 30770300

For registration and FAQ on participation:

Registration & FAQ

We look forward to your registration!

Download programme